Systematic review with network meta‐analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, December 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet
twitter: 30 X users

guideline: 2 clinical guideline sources

Readers on

mendeley: 64 Mendeley

So far, Altmetric has seen 50 X posts from 30 X users, with an upper bound of 105,723 followers.

@APandT https://t.co/UqaCbMCQoc

RT @ShahidaDin1: @alex_ford12399 @JonnyBlackwell @PhilSmithIsBack @FrontGastro_BMJ @BSGTrainees @BSGNurses @Scot_Right @RCPEdin @ResearchBs…

@alex_ford12399 @JonnyBlackwell @PhilSmithIsBack @FrontGastro_BMJ @BSGTrainees @BSGNurses @Scot_Right @RCPEdin @ResearchBsg @ScotSocGastro @WAGE_media @ulstergastro @PlevrisN 🙌🏽agree it helped to focus our minds with the RCT data, galvanise our efforts …

RT @john_damianosMD: Risk of herpes zoster by inflammatory bowel disease medication class 🔥 🥇JAK inhibitors (low dose NNH 265, high dose 11…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 46 additional X posts.